Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification

Xinan Wang,Ziwei Zhang,Yi Ding,Tony Chen,Lorelei Mucci,Demetrios Albanes,Maria Teresa Landi,Neil E. Caporaso,Stephen Lam,Adonina Tardon,Chu Chen,Stig E. Bojesen,Mattias Johansson,Angela Risch,Heike Bickeböller,H-Erich Wichmann,Gadi Rennert,Susanne Arnold,Paul Brennan,James D. McKay,John K. Field,Sanjay S. Shete,Loic Le Marchand,Geoffrey Liu,Angeline S. Andrew,Lambertus A. Kiemeney,Shan Zienolddiny-Narui,Annelie Behndig,Mikael Johansson,Angie Cox,Philip Lazarus,Matthew B. Schabath,Melinda C. Aldrich,Rayjean J. Hung,Christopher I. Amos,Xihong Lin,David C. Christiani

DOI: https://doi.org/10.1186/s13073-024-01298-4

IF: 15.266

2024-02-07

Genome Medicine

Abstract:Although polygenic risk score (PRS) has emerged as a promising tool for predicting cancer risk from genome-wide association studies (GWAS), the individual-level accuracy of lung cancer PRS and the extent to which its impact on subsequent clinical applications remains largely unexplored.

genetics & heredity

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper aims to explore the impact of uncertainty in individual-level polygenic risk scores (PRS) for lung cancer on risk stratification. Although polygenic risk scores (PRS) have emerged as a promising tool for predicting cancer risk from genome-wide association studies (GWAS), their accuracy at the individual level and the implications for subsequent clinical applications have not been fully explored. Specifically, the researchers aim to answer the following questions:

1. **How significant is the uncertainty of lung cancer PRS at the individual level?**
- The researchers constructed lung cancer PRS and their confidence intervals (CI) using two statistical methods: a weighted sum of 16 significant SNP loci derived from GWAS (PRS-16-CV) and a Bayesian method called LDpred2 (PRS-Bayes).

2. **How does this uncertainty affect risk stratification and prediction of PRS?**
- By analyzing the distribution of individual PRS, the researchers assessed the variability of PRS estimates and the coverage of confidence intervals under different methods, and further explored the impact of these uncertainties on risk stratification and predictive performance.

3. **What is the consistency of individual-level risk classification between different PRS estimation methods?**
- The researchers compared the consistency of risk classification at the individual level between different PRS estimation methods (PRS-16, PRS-16-CV, and PRS-Bayes) to evaluate the reliability of different methods in practical applications.

4. **Does considering individual-level uncertainty improve the predictive ability of PRS for lung cancer risk?**
- The researchers used multivariable logistic regression models to evaluate the predictive performance of PRS for lung cancer risk, considering individual-level uncertainty, and compared it with the scenario of using only the mean PRS.

In summary, this paper aims to systematically evaluate the uncertainty of individual-level lung cancer PRS to provide a more accurate and reliable basis for the clinical application of PRS in personalized medicine.